Abnormalities of signal transduction networks in chronic schizophrenia
暂无分享,去创建一个
Jarek Meller | Shruti Marwaha | J. Hammond | S. Marwaha | J. McGuire | Erica A. K. DePasquale | A. Funk | S. O’Donnovan | K. Hasselfeld | V. Hartounian | J. Meador-Woodruff | J. Meller | R. Mccullumsmith | John H. Hammond | James H. Meador-Woodruff | Robert E. McCullumsmith | Kathryn Hasselfeld | Jennifer L. McGuire | Erica A. Depasquale | Adam J. Funk | Sinead M. O’Donnovan | Vahram Hartounian | Kathryn Hasselfeld
[1] V. Haroutunian,et al. Altered serine/threonine kinase activity in schizophrenia , 2014, Brain Research.
[2] U. Alon,et al. The incoherent feedforward loop can provide fold-change detection in gene regulation. , 2009, Molecular cell.
[3] D. Bonchev,et al. A Network Approach to Wound Healing. , 2013, Advances in wound care.
[4] E. Coffey. Nuclear and cytosolic JNK signalling in neurons , 2014, Nature Reviews Neuroscience.
[5] R. Wolff,et al. Influence of CHIEF pathway genes on gene expression: a pathway approach to functionality. , 2014, International journal of molecular epidemiology and genetics.
[6] C. Hall,et al. Regulation of Phosphorylation Pathways by p21 GTPases , 1996 .
[7] Ralph J A Oude Ophuis,et al. DMPK protein isoforms are differentially expressed in myogenic and neural cell lineages , 2009, Muscle & nerve.
[8] R. Belmaker,et al. Psychotropic drugs affect Ser9-phosphorylated GSK-3 beta protein levels in rodent frontal cortex. , 2006, The international journal of neuropsychopharmacology.
[9] J. Milbrandt,et al. The NIMA-family kinase Nek3 regulates microtubule acetylation in neurons , 2009, Journal of Cell Science.
[10] P. Kaliman,et al. Myotonic dystrophy protein kinase (DMPK) and its role in the pathogenesis of myotonic dystrophy 1. , 2008, Cellular signalling.
[11] Shengying Qin,et al. Polymorphisms in epidermal growth factor receptor (EGFR) and AKT1 as possible predictors of clinical outcome in advanced non-small-cell lung cancer patients treated with EGFR tyrosine kinase inhibitors , 2015, Tumor Biology.
[12] E. Rozengurt,et al. Protein kinase D complexes with C-Jun N-terminal kinase via activation loop phosphorylation and phosphorylates the C-Jun N-terminus , 2002, Oncogene.
[13] Jian Zhou,et al. Adenosine Kinase Expression in Cortical Dysplasia With Balloon Cells: Analysis of Developmental Lineage of Cell Types , 2015, Journal of neuropathology and experimental neurology.
[14] V. Haroutunian,et al. Increased G protein-coupled receptor kinase (GRK) expression in the anterior cingulate cortex in schizophrenia , 2014, Schizophrenia Research.
[15] D. Lewis,et al. Selective alterations in prefrontal cortical GABA neurotransmission in schizophrenia: a novel target for the treatment of working memory dysfunction , 2004, Psychopharmacology.
[16] J. Ferrell,et al. Mechanisms of specificity in protein phosphorylation , 2007, Nature Reviews Molecular Cell Biology.
[17] J. David Sweatt,et al. Roles of serine/threonine phosphatases in hippocampel synaptic plasticity , 2001, Nature Reviews Neuroscience.
[18] N. Lamb,et al. Akt1 and Akt2: differentiating the aktion. , 2011, Histology and histopathology.
[19] Tyrone D. Cannon. How Schizophrenia Develops: Cognitive and Brain Mechanisms Underlying Onset of Psychosis , 2015, Trends in Cognitive Sciences.
[20] V. Haroutunian,et al. Glutamate transporter splice variant expression in an enriched pyramidal cell population in schizophrenia , 2015, Translational Psychiatry.
[21] S. Willard,et al. Glutamate, Glutamate Receptors, and Downstream Signaling Pathways , 2013, International journal of biological sciences.
[22] J. Girault,et al. DARPP-32, Jack of All Trades… Master of Which? , 2011, Front. Behav. Neurosci..
[23] J Ludbrook,et al. ADVANTAGES OF PERMUTATION (RANDOMIZATION) TESTS IN CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY , 1994, Clinical and experimental pharmacology & physiology.
[24] W. Maier,et al. Further Evidence for Association of Variants in the AKT1 Gene with Schizophrenia in a Sample of European Sib-Pair Families , 2005, Biological Psychiatry.
[25] Uri Alon,et al. Dynamics and variability of ERK2 response to EGF in individual living cells. , 2009, Molecular cell.
[26] J. Corradi,et al. Altered Expression of CDC42 Signaling Pathway Components in Cortical Layer 3 Pyramidal Cells in Schizophrenia , 2015, Biological Psychiatry.
[27] Stephen J Glatt,et al. Preliminary evidence of ubiquitin proteasome system dysregulation in schizophrenia and bipolar disorder: Convergent pathway analysis findings from two independent samples , 2010, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[28] Anne Fernandez,et al. Akt 1 and Akt 2 : Differentiating the aktion , 2011 .
[29] J. Pratt,et al. Novel treatment strategies for schizophrenia from improved understanding of genetic risk , 2014, Clinical genetics.
[30] K. Stankovic,et al. Metabolomic and Network Analysis of Pharmacotherapies for Sensorineural Hearing Loss , 2014, Otology & neurotology : official publication of the American Otological Society, American Neurotology Society [and] European Academy of Otology and Neurotology.
[31] L. Buée,et al. Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy , 2013, Front. Mol. Neurosci..
[32] Dong Sun Kim,et al. AKT1 polymorphisms and survival of early stage non‐small cell lung cancer , 2012, Journal of surgical oncology.
[33] Harvey J. Motulsky,et al. Detecting outliers when fitting data with nonlinear regression – a new method based on robust nonlinear regression and the false discovery rate , 2006, BMC Bioinformatics.
[34] J. Jaworski,et al. Spatiotemporal Characterization of mTOR Kinase Activity Following Kainic Acid Induced Status Epilepticus and Analysis of Rat Brain Response to Chronic Rapamycin Treatment , 2013, PloS one.
[35] Angus C Nairn,et al. The DARPP-32/protein phosphatase-1 cascade: a model for signal integration 1 Published on the World Wide Web on 22 January 1998. 1 , 1998, Brain Research Reviews.
[36] Yu Xue,et al. GPS 2.1: enhanced prediction of kinase-specific phosphorylation sites with an algorithm of motif length selection. , 2011, Protein engineering, design & selection : PEDS.
[37] D. Shaw,et al. Genetic association of the AKT1 gene with schizophrenia in a British population , 2010, Psychiatric genetics.
[38] J. Javitch,et al. Roles of the Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action. , 2010, The American journal of psychiatry.
[39] D. Gerrard,et al. Effects of AMP-activated protein kinase (AMPK) signaling and essential amino acids on mammalian target of rapamycin (mTOR) signaling and protein synthesis rates in mammary cells. , 2014, Journal of dairy science.
[40] C. Tamminga,et al. Schizophrenia: Evidence implicating hippocampal GluN2B protein and REST epigenetics in psychosis pathophysiology , 2015, Neuroscience.
[41] Lea Goentoro,et al. Evidence that fold-change, and not absolute level, of beta-catenin dictates Wnt signaling. , 2009, Molecular cell.
[42] J. Leek,et al. Temporal dynamics and genetic control of transcription in the human prefrontal cortex , 2011, Nature.
[43] Anthony Holland,et al. Increased MAP kinase activity in Alzheimer's and Down syndrome but not in schizophrenia human brain , 2004, The European journal of neuroscience.
[44] Raquel E. Gur,et al. Src kinase as a mediator of convergent molecular abnormalities leading to NMDAR hypoactivity in schizophrenia , 2014, Molecular Psychiatry.
[45] Daniel J. Mount,et al. Abnormal partitioning of hexokinase 1 suggests disruption of a glutamate transport protein complex in schizophrenia , 2014, Schizophrenia Research.
[46] F. Fumagalli,et al. Antipsychotic drug actions on gene modulation and signaling mechanisms. , 2009, Pharmacology & therapeutics.
[47] C. Hall,et al. Regulation of phosphorylation pathways by p21 GTPases. The p21 Ras-related Rho subfamily and its role in phosphorylation signalling pathways. , 1996, European Journal of Biochemistry.
[48] Ladislav Stacho,et al. Prediction of 492 human protein kinase substrate specificities , 2010, Proteome Science.
[49] Gang Li,et al. Protein kinase D: a new player among the signaling proteins that regulate functions in the nervous system , 2014, Neuroscience Bulletin.
[50] G. Landreth,et al. ERK2 Alone Drives Inflammatory Pain But Cooperates with ERK1 in Sensory Neuron Survival , 2015, The Journal of Neuroscience.
[51] Vladimir I. Vladimirov,et al. AKT1 Is Associated with Schizophrenia Across Multiple Symptom Dimensions in the Irish Study of High Density Schizophrenia Families , 2008, Biological Psychiatry.